MRM-3379 在患有脆性 X 综合征的男性参与者中的 2 期研究
MRM-3379的随机,双盲,安慰剂对照,2阶段研究
This study is a multicenter, double-blind, randomized, placebo-controlled study to assess the safety and tolerability of 3 doses of MRM-3379 in male participants with Fragile X Syndrome ages 16 to 45 (inclusive). In addition, a parallel cohort of participants ages 13 to <16 will receive open-label MRM-3379. All participants will participate for 12 weeks of treatment. The study is also intended as a proof-of-concept investigation to evaluate whether MRM-3379 can improve FXS symptoms
研究概览
地位
条件
研究类型
注册 (估计的)
阶段
- 阶段2
联系人和位置
学习地点
-
-
Arizona
-
Phoenix、Arizona、美国、85006
- 招聘中
- Southwest Autism Research & Resource Center
-
首席研究员:
- Christopher Smith
-
接触:
- Riley Stark
- 电话号码:480-351-0567
- 邮箱:rstark@autismcenter.org
-
接触:
- Padmaja Lakamsani
- 邮箱:PLakamsani@autismcenter.org
-
-
California
-
Irvine、California、美国、92604
- 招聘中
- Amnova Clinical Research, LLC
-
接触:
- Maggie Wang
- 电话号码:949-358-7447
- 邮箱:maggie@amnovaresearch.com
-
首席研究员:
- Gary Feldman
-
接触:
- Jannet Guerrero
- 电话号码:949-861-7479
- 邮箱:jannet.guerrero@amnovaresearch.com
-
Orange、California、美国、92868
- 招聘中
- Children's Hospital of Orange County - Pediatric Subspecialty
-
首席研究员:
- Sailaja Golla
-
接触:
- Adrienne Moore
- 电话号码:714-288-7456
- 邮箱:Adrienne.Moore@choc.org
-
接触:
- Stanley Friers
- 电话号码:(714) 288-7683
- 邮箱:Stanley.Friers@choc.org
-
Sacramento、California、美国、95817
- 招聘中
- Uc Davis Mind Institute
-
接触:
- Melissa Heys
- 电话号码:916-703-0301
- 邮箱:meheys@health.ucdavis.edu
-
接触:
- Abigail Borbe
- 电话号码:916-703-0281
- 邮箱:amoradelhigareda@health.ucdavis.edu
-
首席研究员:
- Randi Hagerman
-
-
Colorado
-
Aurora、Colorado、美国、80045
- 招聘中
- Children's Hospital Colorado
-
首席研究员:
- Nicole Tartaglia
-
接触:
- Nicole Tartaglia
- 电话号码:720-777-6895
- 邮箱:Nicole.Tartaglia@childrenscolorado.org
-
-
Florida
-
Miami、Florida、美国、33136
- 招聘中
- Neurology
-
首席研究员:
- Barbara Coffey
-
接触:
- Dr. Barbara Coffey
- 电话号码:305-243-2759
- 邮箱:bjc134@miami.edu
-
-
Georgia
-
Atlanta、Georgia、美国、30322
- 招聘中
- Emory University - The Emory Clinic - Clifton Road
-
接触:
- Robin Vinson
- 电话号码:404-778-8533
- 邮箱:robin.vinson@emory.edu
-
首席研究员:
- Amy Talboy
-
接触:
- Nadia Ali
- 电话号码:404-778-8613
- 邮箱:nadia.ali@emory.edu
-
-
Illinois
-
Chicago、Illinois、美国、60612
- 招聘中
- Rush University Medical Center-Clinical Operation
-
首席研究员:
- Elizabeth Berry-Kravis
-
接触:
- Lorelai Konen
- 电话号码:312-942-2815
- 邮箱:Lorelai_Konen@rush.edu
-
接触:
- Molly Flanagan
- 电话号码:312-942-1876
- 邮箱:Molly_L_Flanagan@rush.edu
-
-
Maryland
-
Baltimore、Maryland、美国、21205
- 招聘中
- Kennedy Krieger Institute, John Hopkins School of Medicine
-
首席研究员:
- Stephanie Morris
-
接触:
- Kennedy Krieger
- 电话号码:443-923-3850
- 邮箱:ResearchTrials@KennedyKrieger.org
-
-
Massachusetts
-
Boston、Massachusetts、美国、02115
- 招聘中
- Boston Children's Hospital
-
首席研究员:
- Lisa Prock
-
接触:
- Michelle Coughlin
- 电话号码:857-218-3842
- 邮箱:michelle.Coughlin@childrens.harvard.edu
-
接触:
- Katherine Pawlowski
- 电话号码:857-218-5472
- 邮箱:Katherine.pawlowski@childrens.harvard.edu
-
Worcester、Massachusetts、美国、01655
- 招聘中
- UMass Memorial Health
-
接触:
- Taylor Merk
- 电话号码:774-455-4119
- 邮箱:Taylor.merk@umassmed.edu
-
接触:
- Lauren Venuti
- 电话号码:774-455-4113
- 邮箱:Lauren.venuti@umassmed.edu
-
首席研究员:
- Isha Jalnapurkar
-
-
Minnesota
-
Minneapolis、Minnesota、美国、55414
- 招聘中
- University of Minnesota Department of Medicine
-
接触:
- Brittany Faanes
- 电话号码:612-625-5929
- 邮箱:Grego318@umn.edu
-
首席研究员:
- Amy Esler
-
接触:
- Rachel Floersch
- 电话号码:612-626-8424
- 邮箱:Floer013@umn.edu
-
-
Ohio
-
Cincinnati、Ohio、美国、42229
- 招聘中
- Cincinnati Children's Hospital Medical Center
-
首席研究员:
- Rana Elmaghraby
-
接触:
- Hannah Sachs
- 电话号码:513-803-1150
- 邮箱:Hannah.Sachs@cchmc.org
-
接触:
- Priya Ramesh
- 电话号码:513-636-4433
- 邮箱:Priya.Ramesh@cchmc.org
-
-
Pennsylvania
-
Media、Pennsylvania、美国、19063
- 招聘中
- Suburban Research Associates
-
首席研究员:
- Kristen Dopf
-
接触:
- Naya Square
- 电话号码:1128 610-891-9024
- 邮箱:Nsquare@suburbanresearch.com
-
-
Utah
-
Salt Lake City、Utah、美国、84108
- 尚未招聘
- Intermountain Healthcare - Park City Specialty Clinic
-
首席研究员:
- Victoria Wilkins
-
接触:
- Peter Farr
- 电话号码:801-587-2103
- 邮箱:peter.farrell@hsc.utah.edu
-
接触:
- Karina Mattson
- 电话号码:801-587- 7573
- 邮箱:karina.mattson@hsc.utah.edu
-
-
-
-
-
Barcelona、西班牙、08950
- 招聘中
- Sant Joan De Deu Barcelona Hospital
-
接触:
- Ana Gutierrez
- 电话号码:80947 607-797-244
- 邮箱:ana.gutierrezg@sjd.es
-
接触:
- Genís Oña Esteve
- 电话号码:80948 607-799-616
- 邮箱:genis.ona@sjd.es
-
首席研究员:
- Mercedes Serrano Gimare
-
Barcelona、西班牙、08208
- 招聘中
- Parc Tauli Hospital Universitari
-
接触:
- Aida Gonzalez
- 电话号码:80817 +34 93 723 10 10
- 邮箱:agonzalezru01@tauli.cat
-
首席研究员:
- Ana Roche-Martinez
-
Málaga、西班牙、29009
- 招聘中
- Hospital Regional Universitario de Málaga (H. Civil)
-
接触:
- Jonathan Dawood
- 电话号码:+34 620 25 35 35
- 邮箱:jonathanjosepd@gmail.com
-
首席研究员:
- Jesús Herrera- Imbroda
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Willing and able to provide signed informed consent/assent. Where local regulations permit inclusion of participants deemed unable to provide informed consent, a legally authorized representative must provide informed consent on the participant's behalf, and the participant must provide assent if applicable.
- Male, 13-45 years of age (inclusive)
- Weight ≥30 kg and BMI between 18 and 36 kg/m2 (inclusive) at the screening visit
- Diagnosis of FXS with a molecular genetic ≥200 CGG repetitions .
- Able to perform the PVT and ORRT of the NIH-TCB
- Have a consistent caregiver(s) who is willing and able to be present regularly and reliably with the participant
- Able to swallow tablets or capsules
Exclusion Criteria:
History of or current medical condition other than FXS and related issues that would place the participant at higher risk from study participation
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:双倍的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Arm 1: Low Dose of MRM-3379
Participants 16-45 years of age randomized to this arm will receive the low dose of MRM-3379 |
Oral capsule |
|
实验性的:Arm 2: Middle dose of MRM-3379
Participants 16-45 years of age randomized to this arm will receive the middle dose of MRM-3379 |
Oral capsule |
|
实验性的:Arm 3: High dose of MRM-3379
Participants 16-45 years of age randomized to this arm will receive the high dose of MRM-3379 |
Oral capsule |
|
安慰剂比较:Arm 4 :Placebo
Participants 16-45 years of age randomized to this arm will receive Placebo |
Capsules matched to study drug without the active pharmaceutical ingredient |
|
实验性的:Arm 5: Low dose of MRM-3379 Open-Label
Participants 13 to < 16 years of age will receive the low dose of MRM-3370 Open-Label |
Oral capsule |
研究衡量的是什么?
主要结果指标
结果测量 |
大体时间 |
|---|---|
|
治疗中出现的不良事件的发生率和严重程度以及因不良事件而停药和因不良事件而停药
大体时间:基线到第12周
|
基线到第12周
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.